Study on pharmacokinetics and relative bioavailabity of Sparfloxacin Capsules

廉江平,张新,张鹏,赵广荣,周霞芬
DOI: https://doi.org/10.3969/j.issn.1004-2407.2008.06.025
2008-01-01
Abstract:Objective To compare the pharmacokinetics and bioavailability between two kinds of sparfloxacin capsules and to evaluate the bioequivalence of the two preparations.Methods A single dose of 300 mg test capsule or reference capsule of sparfloxacin was administered by randomized crossover way in 18 healthy male volunteers and the plasma concentrations of the sparfloxacin were determined by HPLC.The pharmacokinetic parameters were calculated with BAPP2.0 pharmacokinetic program and the bioavai-lability was evaluated.Results The pharmacokinetic parameters of the test preparation vs.the reference preparation were as follows:Cmax :(1 205.36±390.85)and(1 143.01±309.33)μg·L-1 ;tmax:(4.3±1.1)and(4.4±1.0)h;AUC0~96 h :(33 365.80±9 661.41)and(31 571.94±7 733.55)μg·h·L-1;AUC0~∞(35 753.55±9 909.80)and(33 880.92±8 113.03)μg·h·L-1.The relative bioavai-lability of test sparfloxacin capsule was(105.10±11.20)%.Conclusion The test sparfloxacin and the reference one are bioequivalent.The concentration-time curves of two preparations fitted two compartments mode1.
What problem does this paper attempt to address?